
Omnazide TZ 1gm/125mg Injection
Marketer
Innovative Pharmaceuticals
Salt Composition
Ceftazidime (1gm) + Tazobactum (125mg)
Overview Omnazide TZ 1gm/125mg Injection
Combiflox TZ Injection (1g/125mg) is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby halting infection progression. Administration should strictly adhere to a healthcare provider's guidance. Complete the prescribed regimen; premature cessation may compromise efficacy. Report any missed doses immediately. Commonly reported adverse effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions necessitate immediate medical attention. Allergic responses (rash, pruritus, edema, dyspnea) require prompt emergency care. Disclose all current medications to your physician prior to commencing treatment. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occur. Adequate rest, nutrition, and hydration are vital for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Primary Ingredients of Omnazide TZ 1gm/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Omnazide TZ 1gm/125mg Injection
Infections caused by bacteria
Major Benefits of Omnazide TZ 1gm/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Omnazide TZ 1gm/125mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Omnazide TZ 1gm/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Omnazide TZ 1gm/125mg Injection works:
Omnazide TZ Injection (1g ceftazidime/125mg tazobactam) combines the antibiotic ceftazidime with the beta-lactamase inhibitor tazobactam. Ceftazidime disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactam counters bacterial resistance mechanisms, thereby boosting ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Omnazide TZ 1gm/125mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Omnazide TZ (1g/125mg) is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no harm to the fetus; nonetheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
TZ Injection, containing Omnazide 1gm/125mg, presents minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, posing no appreciable threat to the infant.
DrivingUNSAFE
The injection Omnazide TZ (1 gm/125 mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
The injectable formulation of Omnazide TZ (1 gm/125 mg) requires careful administration in individuals with impaired renal function. Dosage modification for Omnazide TZ (1 gm/125 mg) injection may be necessary. Physician consultation is recommended.
LiverCAUTION
The injectable formulation of Omnazide TZ (1 gm/125 mg) requires careful administration in individuals suffering from significant hepatic impairment. Dosage modification of Omnazide TZ (1 gm/125 mg) injection may be necessary. Physician consultation is advised.
What if you forget to take Omnazide TZ 1gm/125mg Injection :
Should you forget a scheduled dose of Omnazide TZ 1gm/125mg Injection, seek medical advice.
Facts to Know About Omnazide TZ 1gm/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
